Direktorat Registrasi ObatValid

TRIPLIXAM

BPOM Number: DKI2131600817A1
Approved: 26 August 2025
Expiry: 24 August 2030
Form: TABLET SALUT SELAPUT

About This Registration

TRIPLIXAM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2131600817A1. Its current registration status is Valid, with the licence valid until 24 August 2030. The product is registered to GENERO PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in August 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 1 BOTOL PLASTIK @ 30 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

GENERO PHARMACEUTICALS - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

GENERO PHARMACEUTICALS - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (9)

AMLODIPINE BESILATE<AMLODIPINE BESILATE&LTBR>BR&GTINDAPAMIDE<INDAPAMIDE&LTBR>BR&GTPERINDOPRIL ARGININE

Market Intelligence

Owner Portfolio: GENERO PHARMACEUTICALS - INDONESIA holds 68 BPOM registrations
Manufacturer Scale: GENERO PHARMACEUTICALS - INDONESIA produces 68 registered products
Registration Age: Registered for 1 year, 1 month